InfuSystems Holdings Inc (INFU) - Net Assets
Based on the latest financial reports, InfuSystems Holdings Inc (INFU) has net assets worth $58.75 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($98.66 Million) and total liabilities ($39.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check INFU financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $58.75 Million |
| % of Total Assets | 59.55% |
| Annual Growth Rate | N/A |
| 5-Year Change | 18.76% |
| 10-Year Change | 13.09% |
| Growth Volatility | 26.42 |
InfuSystems Holdings Inc - Net Assets Trend (2005–2025)
This chart illustrates how InfuSystems Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore InfuSystems Holdings Inc asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for InfuSystems Holdings Inc (2005–2025)
The table below shows the annual net assets of InfuSystems Holdings Inc from 2005 to 2025. For live valuation and market cap data, see INFU stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $57.33 Million | -0.35% |
| 2024-12-31 | $57.53 Million | +9.99% |
| 2023-12-31 | $52.30 Million | +8.96% |
| 2022-12-31 | $48.00 Million | -0.56% |
| 2021-12-31 | $48.27 Million | +18.45% |
| 2020-12-31 | $40.75 Million | +82.47% |
| 2019-12-31 | $22.33 Million | +9.26% |
| 2018-12-31 | $20.44 Million | -33.96% |
| 2017-12-31 | $30.95 Million | -38.94% |
| 2016-12-31 | $50.69 Million | -1.15% |
| 2015-12-31 | $51.28 Million | +10.39% |
| 2014-12-31 | $46.45 Million | +8.73% |
| 2013-12-31 | $42.72 Million | +6.77% |
| 2012-12-31 | $40.01 Million | -0.38% |
| 2011-12-31 | $40.16 Million | -52.83% |
| 2010-12-31 | $85.14 Million | +4.51% |
| 2009-12-31 | $81.47 Million | +1.74% |
| 2008-12-31 | $80.07 Million | +16.45% |
| 2007-12-31 | $68.76 Million | +5.55% |
| 2006-12-31 | $65.15 Million | +17326105.32% |
| 2005-12-31 | $-376.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to InfuSystems Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6067721700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.00K | 0.00% |
| Other Comprehensive Income | $565.00K | 0.99% |
| Other Components | $117.46 Million | 204.90% |
| Total Equity | $57.33 Million | 100.00% |
InfuSystems Holdings Inc Competitors by Market Cap
The table below lists competitors of InfuSystems Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Invicta
JSE:IVT
|
$165.74 Million |
|
Jakarta Setiabudi Internasional
JK:JSPT
|
$165.76 Million |
|
Socovesa
SN:SOCOVESA
|
$165.94 Million |
|
Black Spade Acquisition II Co Unit
NASDAQ:BSIIU
|
$165.94 Million |
|
LAUNCH TECH CO. H YC-01
F:LAN
|
$165.68 Million |
|
Jalles Machado S/A
SA:JALL3
|
$165.67 Million |
|
Kao Hsiung Chang Iron & Steel Corp
TW:2008
|
$165.66 Million |
|
Rich Development Co Ltd
TWO:5512
|
$165.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in InfuSystems Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 57,529,000 to 57,326,000, a change of -203,000 (-0.4%).
- Net income of 6,627,000 contributed positively to equity growth.
- Share repurchases of 10,974,000 reduced equity.
- Other comprehensive income decreased equity by 554,000.
- Other factors increased equity by 4,698,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.63 Million | +11.56% |
| Share Repurchases | $10.97 Million | -19.14% |
| Other Comprehensive Income | $-554.00K | -0.97% |
| Other Changes | $4.70 Million | +8.2% |
| Total Change | $- | -0.35% |
Book Value vs Market Value Analysis
This analysis compares InfuSystems Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.56x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $0.00 | $9.66 | x |
| 2006-12-31 | $4.77 | $9.66 | x |
| 2007-12-31 | $3.76 | $9.66 | x |
| 2008-12-31 | $4.29 | $9.66 | x |
| 2009-12-31 | $4.30 | $9.66 | x |
| 2010-12-31 | $4.32 | $9.66 | x |
| 2011-12-31 | $1.91 | $9.66 | x |
| 2012-12-31 | $1.87 | $9.66 | x |
| 2013-12-31 | $1.94 | $9.66 | x |
| 2014-12-31 | $2.06 | $9.66 | x |
| 2015-12-31 | $2.24 | $9.66 | x |
| 2016-12-31 | $2.24 | $9.66 | x |
| 2017-12-31 | $1.36 | $9.66 | x |
| 2018-12-31 | $0.95 | $9.66 | x |
| 2019-12-31 | $1.07 | $9.66 | x |
| 2020-12-31 | $1.88 | $9.66 | x |
| 2021-12-31 | $2.19 | $9.66 | x |
| 2022-12-31 | $2.23 | $9.66 | x |
| 2023-12-31 | $2.42 | $9.66 | x |
| 2024-12-31 | $2.65 | $9.66 | x |
| 2025-12-31 | $2.72 | $9.66 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently InfuSystems Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.56%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.62%
- • Asset Turnover: 1.43x
- • Equity Multiplier: 1.75x
- Recent ROE (11.56%) is above the historical average (-5.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-24.75K |
| 2006 | -12.06% | 0.00% | 0.00x | 1.54x | $-14.37 Million |
| 2007 | -4.07% | -42.48% | 0.06x | 1.69x | $-9.67 Million |
| 2008 | 12.44% | 28.12% | 0.30x | 1.45x | $1.95 Million |
| 2009 | 0.95% | 1.99% | 0.34x | 1.41x | $-7.37 Million |
| 2010 | -2.18% | -3.92% | 0.36x | 1.53x | $-10.37 Million |
| 2011 | -113.14% | -83.17% | 0.72x | 1.90x | $-49.46 Million |
| 2012 | -3.72% | -2.53% | 0.76x | 1.94x | $-5.49 Million |
| 2013 | 3.91% | 2.68% | 0.80x | 1.81x | $-2.60 Million |
| 2014 | 7.23% | 5.05% | 0.83x | 1.73x | $-1.29 Million |
| 2015 | 7.30% | 5.19% | 0.75x | 1.88x | $-1.38 Million |
| 2016 | -0.44% | -0.31% | 0.73x | 1.90x | $-5.29 Million |
| 2017 | -66.90% | -29.13% | 1.03x | 2.23x | $-23.80 Million |
| 2018 | -5.36% | -1.63% | 1.05x | 3.13x | $-3.14 Million |
| 2019 | 6.09% | 1.68% | 1.02x | 3.55x | $-872.40K |
| 2020 | 42.53% | 17.80% | 1.00x | 2.38x | $13.26 Million |
| 2021 | 2.94% | 1.39% | 1.05x | 2.02x | $-3.41 Million |
| 2022 | 0.04% | 0.02% | 1.11x | 2.07x | $-4.78 Million |
| 2023 | 1.67% | 0.69% | 1.22x | 1.97x | $-4.36 Million |
| 2024 | 4.08% | 1.74% | 1.30x | 1.80x | $-3.41 Million |
| 2025 | 11.56% | 4.62% | 1.43x | 1.75x | $894.40K |
Industry Comparison
This section compares InfuSystems Holdings Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,920,959,967
- Average return on equity (ROE) among peers: -107.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| InfuSystems Holdings Inc (INFU) | $58.75 Million | 0.00% | 0.68x | $165.69 Million |
| Abbott Laboratories (ABT) | $17.48 Billion | 27.92% | 1.43x | $151.99 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $18.68 Million |
| Aethlon Medical Inc (AEMD) | $-704.50K | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $784.36K | -284.06% | 0.72x | $10.14 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $10.18 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.99 Million |
| Artivion Inc (AORT) | $148.69 Million | 4.92% | 0.18x | $1.09 Billion |
| Apyx Medical Inc (APYX) | $412.30K | -37.38% | 7.73x | $153.68 Million |
About InfuSystems Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment … Read more